HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: Influence on clinical subgroups and prognosis

Seminars in Arthritis and Rheumatism

Volumn 34, Issue 1, 2004, Pages 454-464

  Martínez Taboda, Víctor M ^a,b   Bartolome, Ma Jose ^b   Lopez Hoyos, Marcos ^b   Blanco, Ricardo ^a   Mata, Cristina ^a   Calvo, Jaime ^c   Corrales, Alfonso ^d   Rodriguez Valverde, Vicente ^a  

^a Division of Rheumatology   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL SIERRALLANA   (Spain)

^d HOSPITAL DE LAREDO   (Spain)

Author keywords

giant cell (temporal) arteritis; HLA DRB1; Polymyalgia rheumatica; Spain

Indexed keywords

CORTICOSTEROID; HLA DR ANTIGEN; PREDNISONE;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC POLYMYALGIA; STATISTICAL SIGNIFICANCE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HLA-DR ANTIGENS; HUMANS; INCIDENCE; MALE; POLYMYALGIA RHEUMATICA; PROBABILITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SPAIN; TEMPORAL ARTERITIS;

EID: 4043119071     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2003.12.001     Document Type: Article

References (52)

1. Salvarani C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med. 347:2003;261-271
2. Healey L.A. Long-term follow-up of polymyalgia rheumatica Evidence for synovitis. Semin Arthritis Rheum. 13:1984;322-328
3. O'Duffy J.D., Wahner H.W., Hunder G.G. Joint imaging in polymyalgia rheumatica. Mayo Clin Proc. 51:1976;519-524
4. Paice E.W., Wright F.W., Hill A.G.S. Sternoclavicular erosions in polymyalgia rheumatica. Ann Rheum Dis. 42:1983;379-383
5. Bruk M.I. Articular and vascular manifestations of polymyalgia rheumatica. Ann Rheum Dis. 26:1967;103-113
6. Meliconi R., Pulsatelli L., Uguccioni M., Salvarani C., Macchioni P., Melchiorri C., et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum. 39:1996;199-207
7. Salvarani C., Cantini F., Olivieri I., Barozzi L., Macchioni L., Niccoli L., et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med. 127:1997;27-31
8. Rodríguez-Valverde V., Sarabia J.M., González-Gay M.A., Figueroa M., Armona J., Blanco R., et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med. 102:1997;331-336
9. Wagner A.D., Goronzy J.J., Weyand C.M. Functional profile of tissue infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest. 94:1994;1134-1140
10. Roche N.E., Fulbright J.W., Wagner A.D., Hunder G.G., Goronzy J.J., Weyand C.M. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 36:1993;1286-1294
11. Weyand C.M., Hicok K.C., Hunder G.G., Goronzy J.J. Tissue cytokine patterns distinguish polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 121:1994;484-491
12. Martinez-Taboada V.M., Goronzy J.J., Weyand C.M. Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol. 21:1994;293-299
13. Weyand C.M., Goronzy J.J. Medium- and large-vessel vasculitis. N Engl J Med. 349:2003;160-169
14. Weyand C.M., Goronzy J.J. Giant cell arteritis as an antigen driven disease. Rheum Dis Clin North Am. 21:1995;1027-1039
15. Martinez-Taboada V., Hunder N.N.H., Hunder G.G., Weyand C.M., Goronzy J.J. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med. 74:1996;695-703
16. Brack A., Geisler A., Martínez-Taboada V., Younge B.R., Goronzy J.J., Weyand C.M. Giant cell vasculitis is a T cell-dependent disease. Mol Med. 8:1997;530-543
17. Machado E.B.V., Michet C.J., Ballard D.J., Hunder G.G., Beard C.M., Chu C.P., et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 31:1988;745-749
18. Baldursson O., Steinsson K., Bjornsson J., Lie J.T. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 37:1994;1007-1012
19. Salvarani C., Macchioni P., Zizzi F., Mantovani W., Rossi F., Castri C., et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum. 34:1991;351-356
20. Weyand C.M., Hicok K.C., Hunder G.G., Goronzy J.J. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest. 90:1992;2355-2361
21. Cid M.C., Ercilla G., Vilaseca J., Sanmarti R., Villalta J., Ingelmo, et al. Polymyalgia rheumatica A syndrome associated with HLA-DR4 antigen. Arthritis Rheum. 31:1988;678-682
22. Weyand C.M., Hunder N.H., Hicok K.C., Hunder G.G., Goronzy J.J. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum. 37:1994;514-520
23. Guerne P.A., Salvi M., Seitz M., Bruhlmann P., Rivier G., Frey D., et al. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for research on HLA in polymyalgia rheumatica. J Rheumatol. 24:1997;671-676
24. Bartolome M.J., Martínez-Taboda V.M., Lopez-Hoyos M., Blanco R., Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis Genetic and T cell repertoire analysis. Clin Exp Rheumatol. 19:2001;259-264
25. Fietta P., Manganelli P., Zanetti A., Neri T.M. Familial giant cell arteritis and polymyalgia rheumatica Aggregation in 2 families. J Rheumatol. 29:2002;1551-1555
26. Weyand C.M., Martinez-Taboada V., Goronzy J.J. Current ideas in the role of HLA molecules in human disease. Clin Immunol Newsletters. 16:1996;14-21
27. Haworth S., Ridgeway J., Stewart I., Dyer P.A., Pepper L., Ollier W. Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404. Br J Rheumatol. 35:1996;632-635
28. Combe B., Sany J., Le Quellec A., Clot J., Eliaou J.F. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. J Rheumatol. 25:1998;94-98
29. Dababneh A., Gonzalez-Gay M.A., Garcia-Porrua C., Hajeer A., Thomson W., Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol. 25:1998;2140-2145
30. Salvarani C., Boiardi L., Mantovani V., Ranzi A., Cantini F., Olivieri I., et al. HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy Correlation with disease severity. Ann Rheum Dis. 58:1999;303-308
31. Salvarani C., Boiardi L., Mantovani V., Ranzi A., Cantini F., Olivieri I., et al. HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy. J Rheumatol. 26:1999;2395-2399
32. Reviron D., Foutrier C., Guis S., Mercier P., Roudier J. DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France. Eur J Immunogenet. 28:2001;83-87
33. Gonzalez-Gay M.A., Rodriguez-Valverde V., Blanco R., Fernandez Sueiro J.L., Armona J., Figueroa M., et al. Polymyalgia rheumatica without significantly increased ESR A more benign syndrome. Arch Intern Med. 157:1997;317-320
34. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthrirtis Rheum. 33:1990;1122-1128
35. Armona J., Rodríguez-Valverde V., González-Gay M.A., Figueroa M., Fernández-Sueiro J.L., Blanco R., et al. Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Barc). 105:1995;734-737
36. González-Gay M.A., Blanco R., Rodríguez-Valverde V., Martínez-Taboada V.M., Delgado M., Figueroa M., et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors and response to treatment. Arthritis Rheum. 41:1998;1497-1504
37. Martínez-Taboada V., Brack A., Hunder G.G., Goronzy J.J., Weyand C.M. the inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol. 23:1996;1011-1014
38. Brack A., Martínez-Taboada V., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 42:1999;311-317
39. Fito C., Martínez-Taboada V.M., Blanco R., Sánchez-Andrada S., Rodríguez-Valverde V., Figueroa M., et al. Long-term outcome of 162 patients with polymyalgia rheumatica. Arthritis Rheum. 41:(Suppl):1998;S356. (abstr)
40. Hunder G.G., Sheps S.G., Allen G.L., Joyce J.W. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis Comparison in a prospective study. Ann Intern Med. 82:1975;613-618
41. Catoggio L.J., Soriano E.R., Imamura P.M. Efficacy of low dose steroids in polymyalgia rheumatica (PMR). Arthritis Rheum. 40:(Suppl):1997;S69. (abstr.)
42. Chuang T.-Y., Hunder G.G., Ilstrup D.M., Kurland L.T. Polymyalgia rheumatica A 10-year epidemiologic and clinical study. Ann Intern Med. 97:1982;672-680
43. Bodmer J.G., Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Charron D., et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens. 49:1997;297-321
44. Rincon I., Escalante A. HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans. Arthritis Rheum. 42:1999;1329-1338
45. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 19:1955;251-253
46. Jacobsen S., Baslund B., Madsen H.O., Tvede N., Svejgaard A., Garred P. Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J Rheumatol. 29:2002;2148-2153
47. Sanchez-Velasco P., Escribano J., Paz-Miguel J.E., Ocejo-Vinyals G., Leyva-Cobian F. HLA-DR, DQ nucleotide sequence polymorphisms in the Pasiegos (Pas valleys, Northern Spain) and comparison of the allelic and haplotypic frequencies with those of other European populations. Tissue Antigens. 53:1999;65-73
48. Kyle V., Cawston T.E., Hazleman B. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 48:1989;667-671
49. Ellis M.E., Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis. 42:1983;168-170
50. Martínez-Taboada V.M., Blanco R., Armona J., Uriarte E., Figueroa M., Gonzalez-Gay M.A., et al. Giant cell arteritis with erythrocyte sedimentation rate lower than 50. Clin Rheumatol. 19:2000;73-75
51. Martínez-Taboada V.M., Blanco B., Rodríguez-Valverde V. Polymyalgia rheumatica with low erythrocyte sedimentation rate Clinical aspects. Clin Exp Rheumatol. 18:(Suppl 20):2000;S34-S37
52. Gonzalez-Gay M.A., Garcia-Porrua C., Vazquez-Caruncho M., Dababneh A., Hajeer A., Ollier W. the spectrum of polymyalgia rheumatica in northwestern Spain Incidence and analysis of variables associated with relapse in a 10-year study. J Rheumatol. 26:1999;1326-1332